** = Publikationen gelistet in SCI/SSCI/Pubmed
** Wallner, M; Khafaga, M; Kolesnik, E; Vafiadis, A; Schwantzer, G; Eaton, DM; Curcic, P; Köstenberger, M; Knez, I; Rainer, PP; Pichler, M; Pieske, B; Lewinski, DV
Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
Oncotarget. 2017; 8(30):49264-49274
Doi: 10.18632/oncotarget.17540
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG